Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TBI | Common Stock | Award | $0 | +8.33K | +26.89% | $0.00 | 39.3K | Jan 31, 2023 | Direct | F1, F2 |
transaction | TBI | Common Stock | Award | $0 | +15.6K | +39.71% | $0.00 | 54.9K | Jan 31, 2023 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | On February 7, 2020, the Reporting Person was granted Performance Share Units representing an indeterminate number of shares of Issuer's common stock which were contingent upon the meeting of certain company performance criteria over the 2020-2022 performance period. The level of attainment of the performance criteria was approved on January 31, 2023, resulting in the vesting of the Performance Share Units into shares of the Issuer's common stock on February 3, 2023. |
F2 | This total includes approximately 2,589 shares purchased pursuant to the TrueBlue, Inc. Employee Stock Purchase Plan. |
F3 | On February 5, 2021, the Reporting Person was granted Performance Share Units representing an indeterminate number of shares of Issuer's common stock which were contingent upon the meeting of certain individual performance goals, of which up to 50% could be earned based on performance over the 2021-2022 performance period ("Tranche 1") and up to 50% plus any portion of Tranche 1 not previously earned can be earned based on performance over the 2021-2023 performance period. The level of attainment of the performance goals for Tranche 1 was approved on January 31, 2023, resulting in the vesting of the Performance Share Units into shares of the Issuer's common stock on February 5, 2023, pursuant to the terms of the award. |